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Abstract
Background: Hip fracture is a severe and common injury that occurs predominantly in the elderly. Blood loss in
the perioperative period is associated with a greater risk of dying in anaemic patients. The aim of the study was to
explore the best way to treat stable intertrochanteric fractures, taking hidden blood loss into account.
Methods: This prospective, randomised blinded study included patients aged over 65 years with stable
intertrochanteric fractures (Evans grades I and II). The patients were allocated to one of two groups treated via
extramedullary or intramedullary fixation. Patient data were retrieved from electronic charts. Functional recovery
was evaluated using the Functional Recovery Score of Zuckerman. Postoperative complications were also recorded.
The formula of Nadler and Gross was used to calculate blood loss.
Results: There were 92 patients in the extramedullary and 106 in the intramedullary group. Age, sex, the cause of
injury, the type of fracture, the observed blood loss, functional recovery, time to union, complications, and American
Society of Anesthesiologists classification did not differ significantly between the two groups (all p-values > 0.05). The
frequencies of lung infection, electrolyte imbalance, and hypoproteinemia differed between groups (all p-values < 0.05).
Total and hidden blood loss were higher in the intramedullary group (p = 0.001).
Conclusion: Extramedullary (compared with intramedullary) fixation of stable intertrochanteric fractures significantly
reduces perioperative blood loss but affords similar functional outcomes and times to union. In view of the morbidity
and complications associated with acute anaemia and transfusions, extramedullary fixation may be the optimal choice
for treatment of stable fractures, being associated with reduced blood loss.
Trial registration: The study was retrospectively registered at the Chinese Clinical Trial Registry, number:
ChiCTR-INQ-16009754, trial registration date: 6th Nov. 2016.
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Background
Intertrochanteric fracture is a severe and common injury
that occurs predominantly in the elderly [1–4] and is asso-
ciated with high rates of morbidity and mortality [5–7].
As populations age, the number of hip fractures increase;
the mortality rates range from 15 to 30% [8]. In 2040, an
estimated 512,000 hip fractures will occur in the United
States alone, costing 16 billion dollars (USD) [5].
The optimal implant for repair of intertrochanteric
fractures remains controversial. The options include
extramedullary and intramedullary fixation. Dynamic hip
screw (DHS) fixation is widely used to surgically treat
intertrochanteric femoral fractures via extramedullary
fixation. This device is considered to be the gold stand-
ard for management of such fractures in the elderly [9].
However, the DHS often fails to yield good results when
used to treat unstable and reverse/oblique fractures, lim-
iting the clinical utility thereof [10, 11]. Methods of
intramedullary fixation include gamma nail placement
and proximal femoral nail antirotation (PFNA). Several
randomised controlled trials concluded that intramedul-
lary fixation benefited patients with unstable peritro-
chanteric fractures, being associated with less blood loss
and fewer complications than DHS placement [12, 13].
However, stable intertrochanteric fractures have not
been studied in this context.
Hidden blood loss often occurs after intramedullary
nailing of intertrochanteric fractures. Foss [14] reported
that intramedullary nailing of hip fractures caused more
hidden blood loss than did other forms of fixation, and
arthroplasty. Patients with underlying anaemia are at a
greater risk of dying in the perioperative period than are
others [15, 16].
In many patients, and particularly in the elderly, func-
tional recovery and safety during the perioperative
period are more important than implant selection. The
purpose of the present study was to define the best sur-
gical treatment for stable intertrochanteric fractures, tak-
ing hidden blood loss into account.
Methods
Study population and design
Patients with stable comminuted intertrochanteric fem-
oral fractures (Evans type I or II) [17] were randomised
to a comparison of two different treatment methods in
the trauma centre of our hospital from 2011 to 2014.
The fourth author of this report, who was not involved
in clinical treatment, tossed a coin to assign patients to
one of the two groups (extramedullary or intramedullary
fixation). The three senior surgeons on our team, all of
whom have more than 15 years of clinical experience in
treating intertrochanteric fractures, were familiar with
both techniques. The surgeons (numbered from 1 to 3)
were assigned, in turn, to perform all operations
(extramedullary or intramedullary fixation). Thus, each
surgeon performed similar numbers of both types of op-
erations, minimising surgical bias.
We examined patient records and those of radiological
and functional follow-up examinations. The inclusion
criteria were age over 65 years; the ability to walk inde-
pendently (with or without an aid) prior to fracture; and
sustainment of a low-energy injury within 24 h prior to
admission. The exclusion criteria were as follows: a com-
pound femoral fracture, age under 65 years, a history of
previous femoral fracture, any contraindication to sur-
gery, nonambulatory status prior to the presenting in-
jury, or any other traumatic fracture.
All patients agreed to participate in the trial; written
informed consent was obtained. The study was approved
by the Ethical Board of the Second Affiliated Hospital of
Wenzhou Medical University (Zhejiang, China) and was
performed in accordance with the ethical standards of
the Declaration of Helsinki (1964).
Data collection
The hospital records contained data on sex, age, height,
weight, type of fracture, duration of operation, the
observed blood loss during the operation, preoperative and
postoperative hematocrit (Hct), and laboratory data
(including the preoperative and postoperative hemoglobin
(HB) and albumin levels). Some of the urea and creatinine
levels had to be converted (by us) to mg/dL. The American
Society of Anesthesiologists (ASA) scores were defined by
a staff anaesthetist blinded to the treatment groups.
Blood loss calculation
Total blood loss was calculated from the change in the
Hct level and estimated total blood volume (TBV) de-
rived using Nadler’s formula [18] (which considers sex),
as follows:
Females: blood volume Lð Þ ¼ height mð Þ3  0:3561
þ weight kgð Þ  0:03308
þ 0:1833;
Males: blood volume Lð Þ ¼ height mð Þ3  03669
þ weight kgð Þ  0:03219
þ 0:6041;
Total red blood cell loss Lð Þ ¼ TBV preop:
 Hct preop: − Hct postop:ð Þ;
Total blood loss Lð Þ ¼ Red blood cell loss=Hct preop:
þ volume of blood transfusions given
intraoperatively;
Hidden blood loss ¼ Total blood loss − Observed blood loss:
Perioperative blood loss was calculated using the
above formula and that of Gross [19]. The observed
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blood loss corresponds to the amount of liquid in the
suction bottle minus the amount of liquid used to flush
the wound and the net weight in gauze, gauze pads, and
surgical towels. Laboratory tests were performed pre-
operatively and 1-day postoperatively in the same
laboratory. The criteria for blood transfusion were an Hb
level < 70 g/L or a level < 80 g/L when signs/symptoms of
anaemia were present. The anaesthesia team, who were
blinded to the type of fixation device used, managed fluid
and electrolyte balance and blood transfusion.
Clinical evaluation
The Functional Recovery Score (FRS) questionnaire of
Zuckerman et al. [20] was used to measure functional
recovery 6 and 12 months after operation. This was per-
formed by a staff physical therapist blinded to treatment
allocation, who calculated initial scores on admission
and later administered the instrument again (twice) by
telephone. The Zuckerman questionnaire contains 11
items and yields a score of 0–44; higher scores denote
better functional capacity. Postoperative complications
were assessed and recorded by another author blinded
to the end of the study; wound infection, pneumonia,
urinary tract infection, electrolyte imbalance, and hypo-
proteinemia were noted.
Radiological evaluation
Anteroposterior and lateral hip radiographs were ob-
tained immediately after operation to evaluate the qual-
ity of reduction and fixation of the fracture. Physical
examination was performed, and lateral and anteropos-
terior radiographs of the hip were taken at each follow-
up. Hardware was not routinely removed.
During follow-up, the time to union was assessed.
Radiographic fracture union was defined as recanalisa-
tion of the trabeculae or a bridging callus visible on both
radiographic views; delayed union was defined as no sign
of fracture healing after 6 months; nonunion was defined
as the absence of bone union after 9 months.
Statistical analysis
Descriptive statistics were used to compare the basic
characteristics of the two groups. Data were analysed
using Student’s unpaired test and the chi-squared test. A
p-value < 0.05 was taken to indicate statistical signifi-
cance. Data are given as mean ± standard deviation.
Statistical analyses were performed using SPSS for
Windows software (ver. 19; SPSS Inc., Chicago, IL, USA).
Result
A total of 272 adult patients who suffered stable inter-
trochanteric fracture was assessed (Fig. 1). Thirty-two
patients did not meet the inclusion criteria. A total of 18
patients met the inclusion criteria but were eventually
excluded. Of these, 4 patients were excluded due to severe
medical ailments, and the other 14 declined to accept the
assigned treatment. Therefore, 222 patients, including
82 males and 140 females, of mean age 75.9 years
(range, 65–100 years), met the inclusion criteria and
participated in the study. Of these, a total of 24 were
lost to follow-up for various reasons. The remaining
198 (68 males and 130 females) were followed-up for
an average of 14 months (range, 12–16 months).
The extramedullary and intramedullary fixation groups
were similar. Ninety-two patients were treated via extra-
medullary fixation, 106 via intramedullary fixation. The
extramedullary fixation group contained 29 males and
63 females of mean age 75.9 years (range, 65–88 years).
According to the Evans classification, there were 32
Type-I fractures and 60 Type-II fractures. There were 55
right- and 37 left-side hip injuries. The injury mecha-
nisms included tumble accidents (77 fractures), traffic
accidents (10 fractures), and other causes (5 fractures).
The average time from initial injury to operation was
3.61 days; the average operative time was 44.7 min. The
intramedullary fixation group consisted of 39 males and
67 females of mean age 75.9 years (range, 65–100 years).
According to the Evans classification, there were 30
Type-I fractures and 76 Type-II fractures. There were 56
right- and 50 left-side hip injuries. The injury mecha-
nisms included tumble accidents (80 fractures), traffic
accidents (13 fractures), and other causes (13 fractures).
The average time from initial injury to operation was
3.58 days; the average operative time was 46.3 min
(Table 1). There were no significant differences between
the two groups in any of sex, age, fracture classification,
side of injured hip, injury mechanism, average time from
initial injury to operation, average operative time, or
ASA classification.
The blood loss data are shown in Table 2. There was no
significant between-group difference in any of weight,
height, Hct preop, HB preop, or observed blood loss.
However, the total and hidden blood losses in the extra-
medullary fixation group were lower than those in the
intramedullary fixation group (both p-values = 0.001). The
hidden blood loss was more than the observed blood loss
in both groups (528.37 ± 386.91 mL versus 135.54 ±
36.48 mL and 720.51 ± 408.91 mL vs. 138.92 ± 37.69 mL
for extramedullary and intramedullary fixation groups, re-
spectively). Eight patients in the extramedullary group and
20 in the intramedullary fixation group required intra-
operative blood transfusions due to low blood pressure.
Four patients in the extramedullary and 10 in the intrame-
dullary fixation group received blood transfusions in the
first day after operation due to low Hb levels. The blood
transfusion rate was 13.04% (12/92) in the extramedullary
fixation group, significantly lower than 28.30% (30/106) in
the intramedullary fixation group (p = 0.022; Table 2).
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Table 3 compares the FRSs and times to union in the
two groups. In the extramedullary fixation group, the
FRSs at baseline (pre-operatively) and at 6 and
12 months after surgery were 40.64 ± 2.47, 33.78 ± 3.04,
and 35.96 ± 1.99, respectively, similar to those of the
intramedullary fixation group (scores: 40.43 ± 2.72,
34.25 ± 2.91, and 36.10 ± 2.38; p = 0.577, p = 0.26, and
p = 0.64, respectively). The median scores of the two
groups were lower at 6 and 12 months post-operatively
than pre-operatively, but started to improve at 6 months.
The time to union did not differ significantly between the
extramedullary and intramedullary fixation groups
(13.29 ± 1.22 vs. 12.18 ± 1.30 weeks, respectively, p = 0.526).
In terms of surgical and fracture-healing complications
during follow-up, 5.4% (5/92) of the extramedullary fix-
ation group developed lung infections, 10.87% (10/92)
electrolyte imbalances, and 11.96% (11/92) hypoprotei-
nemia; the figures for the intramedullary fixation group
were 14.2% (15/106), 24.53% (26/106), and 25.47% (27/
106), respectively; the between-group differences were
significant (all p-values < 0.05; Table 4). No deep infec-
tion, delayed union, or nonunion was evident in either
group. Both groups exhibited similar rates of superficial
wound infection, urinary tract infection, mortality, and
cutting of the lag screw (all p-values > 0.05; Table 4). One
patient in the extramedullary fixation group suffered an
implant failure; PFNA was used to heal the fracture. Four
patients in the intramedullary and three in the extrame-
dullary fixation group died during the second year of
follow-up of causes unrelated to their operations.
Discussion
The optimal management of intertrochanteric fractures
remains controversial. DHS and gamma nails have been
most commonly used to fix such fractures over the last
decade [21]. However, PFNA, the latest device, is consid-
ered to be near-perfect; intertrochanteric fractures are
healed with minimal complications [10, 12]. Earlier ran-
domised controlled trials and meta-analyses failed to
reach unanimous conclusions. Lukas [22] performed a
biomechanical in vitro study comparing DHSs and intra-
medullary nails for treatment of intertrochanteric
fractures and found that extra- and intra-medullary
osteosynthesis were comparable in terms of post-
operative stiffness and survival during cyclic testing. As
the nail failure load was significantly higher in the
AO31-A2.3 fracture models tested, it was concluded that
intramedullary implants should be preferred when
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) 2010 flow diagram depicting fracture allotment in both groups
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fractures are unstable. Verettas [23], in a prospective
randomised study, found no significant difference be-
tween the two methods of fracture stabilisation in terms
of perioperative systemic effects. DHS placement is safe
and effective, compared with novel intramedullary tech-
niques, in already vulnerable patients with trochanteric
fractures. We show that, in patients with stable fractures,
intramedullary fixation did not afford any advantage.
In terms of functional recovery, Saudan et al. [24]
measured social functioning and mobility 3, 6, and
12 months after surgery featuring PFNA or DHS place-
ment. Although the intermediate findings were not
given, no significant differences at the 1-year follow-up
were evident, in terms of return to pre-fracture levels of
ambulation and independence, between the PFN- and
DHS-treated groups. Thus, it was concluded that intra-
medullary nails (such as the PFN) afforded no advantage
over extramedullary devices (such as the DHS) in treat-
ment of intertrochanteric fractures caused by low-energy
trauma (Evans I and II grades). Another study [25]
compared functional recovery 1 year after trochanteric
nail- or DHS-mediated repair; final assessments were
conducted over the telephone; no between-group differ-
ence in recovery score was noted. In our present study,
we also found that there were no between-group differ-
ences either pre-operatively, or at 6 and 12 months,
when intramedullary nails and extramedullary devices
were placed. We thus suggest that both intramedullary
and extramedullary approaches afford adequate fixation
of stable intertrochanteric fractures. An uninjured, fem-
oral lesser trochanter may be key in this context.
Perioperative blood loss has been associated with in-
creased mortality, infection, deep venous thrombosis,
renal and cardiac decompensation, and poorer func-
tional results [15, 26, 27]; such blood loss should be
considered when managing pertrochanteric fractures.
Reduction of blood loss is one issue in such manage-
ment; prevention of varus displacement, screw, and bone
healing are further considerations. In our opinion, extra-
medullary fixation was associated with less blood loss
than intramedullary fixation. Although the observed
blood loss was similar in the two groups, the hidden
blood loss differed significantly (p = 0.001) for the fol-
lowing reasons. First, the gluteus medius is crossed in
the process of intramedullary fixation; this may damage
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Traffic accident 10 13
Other causes 5 13
Time to operation
(days)
3.61 ± 1.73 3.58 ± 1.57 0.89
Operative time
(min)
44.7 ± 10.2 46.3 ± 8.61 0.24
ASA classification
ASA I 2 3
ASA II 50 53 0.814
ASA III 40 50
Table 2 Comparison the two groups of blood loss
Parameters Extramedullary fixation Intramedullary fixation T or X2 value P value
Sample number (n) 92 106 — —
Weight(kg) 60.56 ± 5.82 59.49 ± 5.56 1.33 0.1
Height(m) 1.64 ± 0.73 1.64 ± 0.7 0.07 0.95
Hematocrit, preop 0.326 ± 0.053 0.316 ± 0.049 1.45 0.15
Hemoglobin, preop (g/dl) 107.87 ± 18.37 104.82 ± 16.78 1.2 0.22
Total blood loss(ml) 663.91 ± 389.32 859.43 ± 411.07 3.42 0.001*
Observed blood loss(ml) 135.54 ± 36.48 138.92 ± 37.69 0.64 0.5
Hidden blood loss(ml) 528.37 ± 386.91 720.51 ± 408.91 3.38 0.001*
Blood transfusion rate 12(13.04%) 30(28.30%) 5.232 0.022*
*Significant value
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the peritrochanteric arterial circuit. Second, insertion of
an intramedullary device requires drilling of the greater
trochanter, thus disturbing bone marrow neoangio-
genesis [28]. In short, intramedullary fixation is associ-
ated with more hidden blood loss; this deserves more
attention.
Several limitations of the study must be acknowledged.
First, our results are based on rather inaccurate assess-
ments of observed and calculated total blood losses. The
precise calculation of blood loss depends on the accur-
acy of blood workups performed at admission and after
surgery, and accurate measurement of intraoperative
blood loss. Also, we did not explore possible con-
founders of blood loss. However, the formulae used have
been applied in related works published in high-quality
international journals, and are both reliable and prac-
tical. Second, our sample size was small; further studies
with larger samples are required to confirm our findings.
We found that the perioperative incidences of pneu-
monia, hypoproteinemia, and electrolyte imbalance were
higher in the intramedullary than the extramedullary fix-
ation group, mainly due to a reduced perioperative blood
volume. Although red cells were infused, total blood loss
reduces the levels of other blood components, triggering
hypoproteinemia, reduced immunity, lung infections,
and other disorders.
Together, our data indicate that the final functional
scores and the times to union were similar in both
groups with stable fractures (Evans I and II grades).
However, blood loss, specifically hidden blood loss, dif-
fered significantly between the groups.
Conclusions
Extramedullary fixation (such as DHS placement) signifi-
cantly reduces perioperative blood loss in patients with
stable intertrochanteric fractures. Such fixation affords
functional outcomes and times to union similar to those
associated with intramedullary fixation. In view of the
morbidity and complications associated with acute an-
aemia and transfusion, extramedullary fixation may be a
good choice in such patients.
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Table 3 Comparison the two groups of function recovery scores and time to union
n Zuckerman FRC Time to
union(w)Pre-operative 6 months 12 months
Extramedullary fixation 92 40.64 ± 2.47 33.78 ± 3.04 35.96 ± 1.99 13.29 ± 1.22
Intramedullary fixation 106 40.43 ± 2.72 34.25 ± 2.91 36.10 ± 2.38 12.18 ± 1.30
Test value 0.558 1.11 0.473 0.635
P value p = 0.577 p = 0.26 p = 0.64 p = 0.526
FRC functional recovery scores
Table 4 Postoperative complications of patients in the two groups
Parameters Extramedullary
fixation (n = 92)
Intramedullary
fixation (n = 106)
P value
Superficial wound infection 4(4.3%) 3(2.8%) 0.42
Deep wound infection 0 0 —
Pneumonia 5(5.4%) 15(14.2%) 0.042*
Urinary tract infection 5(5.4%) 6(5.7%) 0.95
Mortality 3(3.2%) 4(3.8%) 0.58
Delayed union 0 0 —
Nonunion 0 0 —
Cutting of the lag screw 4(4.3%) 3(2.8%) 0.42
Implant failure 1(1.1%) 0 0.47
Electrolyte imbalance 10(10.87%) 26(24.53%) 0.013*
Hypoproteinemia 11(11.96%) 27(25.47%) 0.016*
The values are given as the n(%)
P values for between-group comparisons were determined by the chi-squared
test and Fisher’s exact test for nominal variables
Statistically significant (P value < 0.05)
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